Tweet
<img alt="" height="1" width="1" />
Heart-Test Developer BG Medicine Plans $86.3 Million IPO
Wall Street Journal
BG Medicine Inc. plans to offer up to an estimated $86.3 million of shares in an initial public offering to fund the launch of its lead product candidate, a test for heart failure, and for development of other cardiovascular diagnostic product ...
BG Medicine plans IPO for $86.3 millionBusinessWeek
BG Medicine re-files for IPO, aims for $86MMass High Tech
BG Medicine Re-Files for IPOPrivate Equity Hub (press release)
Medical News Today (press release)
all 23 news articles »
More...